Citrate Versus Citrate–Heparin Anticoagulation in HPC (A): Comparative Effects on Intra‐Apheresis Mobilization of CD34 + Hematopoietic Progenitor Cells
Journal of Clinical Apheresis · 2026-04 · 41 (2)
DOI: 10.1002/jca.70118 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Clinical Apheresis, online erschienen am 27.03.2026. Verfasst von Yandy Marx Castillo-Aleman und 16 weiteren Autor:innen. Beteiligte Einrichtung: Abu Dhabi Stem Cells Center (ADSCC), Abu Dhabi, UAE. Hauptthemen laut MEDLINE: Heparin, Anticoagulants, Citric Acid, Blood Component Removal. Die Arbeit nennt 22 Literaturangaben.
Themen: Mobilisation
Abstract (Originalsprache)
Successful hematopoietic stem cell transplantation relies on the collection of a sufficient number of CD34 + hematopoietic progenitor cells (HPCs). While acid citrate dextrose solution A (ACD‐A) is a common anticoagulant (AC) for HPC apheresis [HPC(A)], recent evidence suggests that concomitant heparin may enhance intra‐apheresis recruitment (IAR) of CD34 + cells and improve collection efficiency. This study aimed to compare citrate‐only and citrate–heparin protocols in routine HPC(A) procedures, with a focus on their effects on IAR and efficiency outcomes. A retrospective analysis was performed on 266 HPC(As) from 193 apheresis donors in autologous and allogeneic settings. Donor demographics, procedural parameters, and collection outcomes were compared between the ACD‐A–only and ACD‐A plus heparin protocols. The study endpoints included apheresis yield (AY/kg), collection efficiencies (CE 1 , CE 2 , and cruCE), recruitment ratio (RR), and performance ratio (PR). Statistical analyses included Mann–Whitney U tests, effect sizes, and partial least squares (PLS) regression. Heparinized procedures demonstrated higher processed total blood volume ratios, lower AC volumes, and superior outcomes across CE 1 (83.8% vs. 72.5%, p = 0.00027), CE 2 (70.8% vs. 64.2%, p = 0.0055), cruCE (77.0% vs. 72.4%, p < 0.0001), RR (2.3 vs. 1.7, p < 0.0001), PR (239.3% vs. 208.2%, p < 0.0001), and AY/kg (6.75 vs. 5.23 × 10 6 CD34 + cells/kg, p = 0.0025). The effect size and PLS analyses confirmed the contribution of heparin as an adjunct AC enhancing multiple apheresis outcomes. In summary, citrate–heparin anticoagulation was found to be a feasible strategy that improved key collection efficiency and IAR metrics during HPC(A).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Abu Dhabi Stem Cells Center (ADSCC), Abu Dhabi, UAE.
- Yas Clinic Khalifa City (YCKC) Hospital, Abu Dhabi, UAE.
- United Arab Emirates University (UAEU), Abu Dhabi, UAE.
ORCID-Profile: Yandy Marx Castillo-Aleman, Carlos Agustin Villegas-Valverde, Antonio Alfonso Bencomo-Hernandez, Shinnette Lumame, Charisma Castelo, Jay Mary Rose-Roque, Marlene Cato, Nameer Al-Saadawi, Mohamed Ibrahim Abu-Haleeqa, Aseel Suleiman Alsaid, Sakher Ahmad Obeidat, Mansi Sachdev, Jayakumar David Dennison, Inas El-Najjar, Rene Antonio Rivero-Jimenez, Yendry Ventura-Carmenate, Fatema Mohammed Al-Kaabi
Zitieren
APA
Castillo-Aleman, Y. M., Villegas-Valverde, C. A., Bencomo-Hernandez, A. A., Lumame, S., Castelo, C., Rose-Roque, J. M., Cato, M., Al-Saadawi, N., Abu-Haleeqa, M. I., Alsaid, A. S., Obeidat, S. A., Sachdev, M., Dennison, J. D., El-Najjar, I., Rivero-Jimenez, R. A., Ventura-Carmenate, Y., & Al-Kaabi, F. M. (2026). Citrate Versus Citrate–Heparin Anticoagulation in HPC (A): Comparative Effects on Intra‐Apheresis Mobilization of CD34 + Hematopoietic Progenitor Cells. Journal of Clinical Apheresis, 41(2). https://doi.org/10.1002/jca.70118
Vancouver
Castillo-Aleman YM, Villegas-Valverde CA, Bencomo-Hernandez AA, Lumame S, Castelo C, Rose-Roque JM, et al. Citrate Versus Citrate–Heparin Anticoagulation in HPC (A): Comparative Effects on Intra‐Apheresis Mobilization of CD34 + Hematopoietic Progenitor Cells. Journal of Clinical Apheresis. 2026;41(2). doi:10.1002/jca.70118
BibTeX
@article{CastilloAleman2026,
author = {Castillo-Aleman, Yandy Marx and Villegas-Valverde, Carlos Agustin and Bencomo-Hernandez, Antonio Alfonso and Lumame, Shinnette and Castelo, Charisma and Rose-Roque, Jay Mary and Cato, Marlene and Al-Saadawi, Nameer and Abu-Haleeqa, Mohamed Ibrahim and Alsaid, Aseel Suleiman and Obeidat, Sakher Ahmad and Sachdev, Mansi and Dennison, Jayakumar David and El-Najjar, Inas and Rivero-Jimenez, Rene Antonio and Ventura-Carmenate, Yendry and Al-Kaabi, Fatema Mohammed},
title = {Citrate Versus Citrate–Heparin Anticoagulation in HPC (A): Comparative Effects on Intra‐Apheresis Mobilization of CD34 + Hematopoietic Progenitor Cells},
journal = {Journal of Clinical Apheresis},
year = {2026},
volume = {41},
number = {2},
doi = {10.1002/jca.70118}
}
EUVIMED